Pharma & Biotech

The fate of CureVac's independent stock market journey has been sealed. BioNTech has successfully cleared the final hurdle for its...

Veru Inc. has officially scheduled the release of its 2025 financial results. The report will be issued on Wednesday, December...

Shares of Viking Therapeutics are currently navigating a challenging technical landscape. Market experts continue to highlight significant long-term potential driven...

Following the termination of its lead candidate's development, Sensei Biotherapeutics is navigating a comprehensive strategic review. The company's leadership is...

CureVac is undergoing a decisive transformation, shifting from an independent mRNA pioneer to a fully integrated unit within BioNTech. With...

Growing optimism surrounds Assembly Biosciences following the release of compelling interim data from its Phase 1b study targeting herpes simplex...

PDS Biotechnology Corporation has recently activated multiple catalysts that could provide fresh impetus for its stock. The company secured a...

The publicly traded chapter for Akero Therapeutics has officially closed. The company’s shares, previously listed under the ticker symbol "AKRO"...

Shares of Sellas Life Sciences are posting significant gains in today's trading session. This upward momentum follows the release of...

Shares of medical device manufacturer Zimmer Biomet are experiencing notable downward pressure in today's trading session. This movement follows disclosures...